StockData

Geospace Technologies vs Harvard Bioscience

GEOS and HBIO side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How GEOS and HBIO compare

Geospace Technologies and Harvard Bioscience are about the same size, with market caps of $44.1M and $40.6M.

Harvard Bioscience grew revenue faster over the last twelve months (−1.1% versus −20.5% for Geospace Technologies).

Harvard Bioscience keeps more of each dollar of sales as profit, with a net margin of −11.9% compared with −43.1% at Geospace Technologies.

Geospace Technologies scores higher on the StockData Score (7 against 3 for Harvard Bioscience), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricGEOSHBIO
Size and price
Market cap$44.1M$40.6M
Share price$3.41$8.91
Change, 1 year−85.9%53.0%
Change, 5 years−61.6%−87.1%
Beta (5Y)0.022.01
Employees519339
StockData Score
Total score7 (better)3
Valuation score3 (better)0
Growth score01 (better)
Performance score01 (better)
Health score4 (better)1
Dividend score00
Valuation
P/S0.5×0.5× (better)
P/B0.5× (better)5.5×
FCF yield−83.7%−2.8% (better)
Fair value$15.48$6.45
Margin of safety78.0% (better)−38.1%
Growth
Revenue growth (TTM)−20.5%−1.1% (better)
Revenue growth, 5Y average4.8% (better)−3.3%
Profitability
Gross margin8.0%58.2% (better)
Operating margin−44.7%−0.28% (better)
Net margin−43.1%−11.9% (better)
FCF margin−40.2%−1.3% (better)
Return on equity−34.4% (better)−89.9%
Return on invested capital−32.1%−0.84% (better)
Financial health
Debt / equity0.004.95 (better)
Interest coverage−539.6×–
Current ratio2.44 (better)1.87
Altman Z-score1.11 (better)−2.22
Piotroski F-score23 (better)
Dividends and buybacks
Buyback yield0.00%–
Shareholder yield0.00%0.00%
Ownership
Held by institutions40.1%36.9%
Held by insiders4.4%–
Insider net buying, 12 months–$202K
Short interest, % of float2.4%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.